Supply chain, logistics

Marken Opens Depot to Support Growth in Chinese Clinical Trials

13-Mar-2013 By Dan Stanton

Marken says the opening of its new pharma depot is part of a whole strategy within China and was driven by demand from an increase in clinical trials. 

FDA Re-Inspection of Hospira’s Rocky Mount Plant Ends with 483

06-Mar-2013 By Zachary Brennan

The US FDA has completed its re-inspection of Hospira’s Rocky Mount, North Carolina, plant and cited the company with 20 violations, three of which were repeat observations, according to an SEC filing.

DSM to Supply Cancer Drug for Eisai

05-Mar-2013 By Dan Stanton

Eisai says its US supply agreement with DSM offers an alternate manufacturing facility and ensures a strengthened supply line.

PRA says Clinstar Takeover Offers Quicker and Cheaper Patient Enrollment

05-Mar-2013 By Gareth Macdonald

US CRO PRA international has expanded its presence in Eastern Europe with the acquisition of privately-owned trial services firm ClinStar.

Cedarburg Hauser's DEA Approval Brings Niche Manufacturing Home

28-Feb-2013 By Dan Stanton

Cedarburg Hauser says US CDMOs are focusing on “niche fields” in order to gain a competitive advantage on foreign competition.

Profectus Shifts to US CMO for DNA Vaccine Production

28-Feb-2013 By Zachary Brennan

Profectus BioSciences has signed up San Diego-based CMO Althea Technologies to manufacture DNA vaccines after its deal with Boehringer Ingelheim ended due to currency issues.

Hospira Recalls Lots of Five Injections as FDA Re-Inspection Continues

27-Feb-2013 By Zachary Brennan

Hospira has announced it is voluntarily recalling multiple lots of five different injections because of customer reports of faulty packaging and contamination. 

Distribution Deals: GVKBIO in Taiwan; Sanofi in Austria

26-Feb-2013 By Dan Stanton

GVK Biosciences says it is looking to target Taiwanese clients following a distribution deal with GGA over its clinical databases.

Lantheus: 'Supplier Diversification' Strategy After Ben Venue Shutdown

13-Feb-2013 By Dan Stanton

The US FDA has expedited approval of Jubilant HollisterStier manufacturing sites in further fallout from Ben Venue’s consent decree.

FDA to Release Long-Awaited Guidance on CMO Agreements, Biosimilars in 2013

04-Feb-2013 By Zachary Brennan

Highly sought-after guidance on quality agreements for contract manufacturing organizations (CMOs) and biosimilar developers is expected in 2013, according to a list of future guidance documents released by the US Food and Drug Administration (FDA).

AmerisourceBergen eyes foreign lands after Q1 results

28-Jan-2013 By Dan Stanton

AmerisourceBergen has announced upbeat Q1 results as contributions from Consulting Services and World Courier offsets ongoing cost issues in Drug Distribution.

GSK Shifts Supplier Invoice Payment Timing, Business Forum Cries Foul

23-Jan-2013 By Zachary Brennan

GlaxoSmithKline has decided to only make once-monthly payments to suppliers, which could increase the amount of time it takes a CRO, CMO or other supplier to be paid for its work.

UPS’ TNT takeover bid fizzles out

14-Jan-2013 By Gareth Macdonald

United Parcel Service (UPS) has abandoned its bid to buy Holland-based logistics firm TNT Express after the European Commission said it would block the deal.

SGS and blue inspection body to be excipact trained

29-Nov-2012 By Gareth Macdonald

The group behind the excipient certification scheme Excipact will train SGS and blue inspection body GmbH auditors under agreements signed this week.

News from CPhI

Single-use lets some Pharmas make own potent drugs but outsourcing demand still strong: Alkermes

22-Nov-2012 By Natalie Morrison

Single-use technology will see more HP production brought in-house but contract manufacturers will still win-out, according to Alkermes.

Catalent's Swindon cuts are result of decline in Zydis demand

21-Nov-2012 By Natalie Morrison

Catalent will cut 45 staff from its Swindon facility after customers reduce Zydis order volumes.

Boehringer set to make E.coli for clinical trials

12-Nov-2012

Molecular Partners has contracted Boehringer Ingelheim to produce a range of highly potent molecules for its clinical pipeline.

News from CPhI

Aesica ramps up HPAPI capacity to meet industry demand

07-Nov-2012 By Natalie Morrison

The technical challenge posed by potent APIs means drug industry demand for R&D-scale contract manufacturing is largely unmet, according to Aesica.

Is Eli Lilly distancing itself from outsourcing?

05-Nov-2012 By Natalie Morrison

Eli Lilly is bringing more production in-house after investing $140m in the expansion of its US insulin site.

News from AAPS

Xcelience plans EU clinical trial supply expansion after opening new US plant

23-Oct-2012 By Natalie Morrison

Xcelience is shopping for a European distributor after opening a new clinical trial supply facility in the US.

Marken recertified as C-TPAT compliant

15-Oct-2012

Trial and sample logistics services firm Marken has been recertified by the US Customs and Border Protection (CBP).

Catalent and Parexel team up to offer clinical trial material supply services

03-Oct-2012 By Natalie Morrison

Catalent and Parexel have teamed up to offer clinical trial material supply services.

update

Apax’s Marken dealmaker quits calling the investment a ‘tough one’

03-Oct-2012 By Gareth Macdonald

The Mann who bought Marken for investment group Apax Partners has stepped down, describing the deal for the logistics contractor as one of the ‘tough ones’.

Lonza to make preclinical antibody conjugates for Intellect Neurosciences

01-Oct-2012 By Gareth Macdonald

Lonza has signed a contract to make preclinical trial supplies of an antibody-drug conjugate (ADC) being developed by Intellect Neurosciences.

EXCLUSIVE STUDY

Open source paradigm could swipe biz from CROs: Beroe

27-Sep-2012 By Natalie Morrison

Open source drug developers could swipe business from CROs in the drug discovery field, according to Beroe.

Almac gets MHRA OK for clinical site and new ERP system

27-Sep-2012 By Gareth Macdonald

The MHRA has given Almac’s Northern Ireland clinical services facility and its new ERP system a thumbs-up after an inspection carried out this month.

Quintiles signs 10-year Mexico deal with Sinclair

18-Sep-2012 By Natalie Morrison

Quintiles will commercialise Sinclair IS Pharma’s products in Mexico under a 10-year licensing agreement.

API production will boost contract pharma manufacturing biz

12-Sep-2012 By Natalie Morrison

Active pharmaceutical ingredient production will be the driving factor behind a predicted boom in the pharmaceutical contract manufacturing market, according to Visiongain.

Regulation, theft and payors dominate pharma supply chain concerns, says UPS

05-Sep-2012 By Gareth Macdonald

Worries about increasing regulatory scrutiny and penalties top the list of API and drugmaker concerns about supply chains according to a survey by contract distributor UPS.

Online drug accountability systems will replace paper, says Cenduit

04-Sep-2012 By Natalie Morrison

Automated drug accountability systems are becoming “the norm” in clinical trials because they can improve compliance and cut working time drastically, according to Cenduit.

Marken adds depots in Germany and the US and eyes Russia and Brazil

03-Sep-2012 By Gareth Macdonald

Marken has set up new clinical trial supply depots in Germany and the US and is eying further expansion in China, Brazil and Russia.

United Drug to buy Bilcare's UK and US trial supply businesses

21-Aug-2012 By Gareth Macdonald

United Drug will buy the UK and US trial supply businesses of Indian contractor Bilcare to further expand its packaging services division.

Theorem and Gallus team up to help drugsmakers in emerging markets go State side

16-Aug-2012 By Natalie Morrison

Theorem and Gallus say their new biologics manufacturing partnership is aimed at giving a “leg up” to drugsmakers in emerging markets looking to market products in the US.

Difficult new biz acquisitions drag PDI's Q2 profits

14-Aug-2012 By Natalie Morrison

Longer-than-expected ramp up in new business gains for PDI has dragged on Q2 earnings results for the firm.

Aurobindo sets eyes on API CRAMS biz

08-Aug-2012 By Natalie Morrison

Aurobindo has announced long term plans to steer away from its generics making business in a bid to focus on long term API manufacturing partnerships.

Almac doubles refrigerator capacity for trial suppliers seeking biologics business

08-Aug-2012 By Gareth Macdonald

Almac has doubled refrigerator capacity at its site in Craigavon, Northern Ireland citing demand from its roster of biologics producing clients.

AstraZeneca and Assay Depot's VRM allows full drug discovery from a laptop

01-Aug-2012 By Natalie Morrison

AstraZeneca and Assay Depot have launched a new “virtual research lab” which they say will allow a small group of scientists to run full drug discovery from a laptop.

Catalent plans single use overhaul of bioreactors

31-Jul-2012 By Natalie Morrison

Catalent has replaced all stainless steel bioreactors at its biologics facility in Middleton, Wisconsin with single-use techs citing cost and flexibility advantages.

UPDATE

All Indian pharmaceutical CMOs must pay the excise duty, says SPIC

23-Jul-2012 By Natalie Morrison

SPIC has pressed the Indian PM to issue a standardised excise duty to all contract manufacturers operating in the country so drugsmakers can have a level playing field.

EXCLUSIVE

CDMO and CRO must become one so clinical research can evolve: Quotient.

05-Jul-2012 By Natalie Morrison

‘Merge CDMO and CRO activities to fix the holes in the early phase clinical research industry’, said Quotient Clinical’s CEO Mark Egerton.

US base will bridge gap for manufacturing in China, says Suzhou pharma

27-Jun-2012 By Natalie Morrison

China-based Suzhou Pharma has set up a US regulatory and QA hub in what it says is a bid to provide Western cGMP (current good manufacturing practice) know-how with low cost Asian production.

Almac launches on-site QP consultation service

14-Jun-2012 By Gareth Macdonald

Almac has come up with a variation on the QP consulting business with a new service that provides on-site oversight.

World Courier key to emerging market growth, ABC CFO says

12-Jun-2012 By Nick Taylor

AmerisourceBergen will use recently acquired World Courier to expand its existing businesses into new markets, its CFO said.

West shifts focus to proprietary products

23-May-2012 By Natalie Morrison

West Pharmaceutical is changing its gauge from contract manufacturing to proprietary products: it’s particular focus, delivery systems.

Marken mulls direct-to-study participant distribution

14-May-2012 By Gareth Macdonald

Marken is looking at setting up a home delivery service as a further expansion of its clinical trial and logistics offering. 

Know how your CMO will deliver its promises, says Baxter

09-May-2012 By Natalie Morrison

“Understand not only what your CMO can do, but how they can get it done,” was Baxter’s message during a speech at the year’s Interphex in New York.

AmerisourceBergen sees Q2 revenue growth

30-Apr-2012

AmerisourceBergen’s commercial services arm was its key driver in Q2, offsetting the loss of key customer for its drug business.

World Courier to open Argentina depot next month

11-Apr-2012 By Gareth Macdonald

World Courier says it will open an expanded trial supply storage depot in Argentina next month citing growing regional demand.

UTi Worldwide reports gains in pharmaceutical volumes

27-Mar-2012 By Nick Taylor

UTi Worldwide reported higher pharmaceutical volumes in the fourth quarter on new business wins and increased client activity.

Pharma needs to rethink supply chains in an era of patent expiry and global outsourcing

26-Mar-2012 By Gareth Macdonald

Planning supply chains early is an important part of maintaining margins but is often overlooked by Pharmas too focused on developing the next product in an era of patent expiry says industry consultant.